The  	The  	 DT	O
importance  	importance  	 NN	O
of  	of  	 IN	O
detecting  	detecting  	 VBG	O
cytomegalovirus  	cytomegalovirus  	 JJ	B-NP
infections  	infections  	 NNS	I-NP
in  	in  	 IN	O
studies  	studies  	 NNS	O
evaluating  	evaluating  	 VBG	O
new  	new  	 JJ	O
therapies  	therapies  	 NNS	O
for  	for  	 IN	O
severe  	severe  	 JJ	O
sepsis  	sepsis  	 JJ	O
Cytomegalovirus  	Cytomegalovirus  	 JJ	B-NP
infection  	infection  	 NN	I-NP
is  	is  	 VBZ	O
present  	present  	 JJ	O
in  	in  	 IN	O
the  	the  	 DT	O
majority  	majority  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
population  	population  	 NN	O
and  	and  	 CC	O
is  	is  	 VBZ	O
associated  	associated  	 VBN	O
with  	with  	 IN	O
substantial  	substantial  	 JJ	O
morbidity  	morbidity  	 NN	O
and  	and  	 CC	O
mortality  	mortality  	 NN	O
in  	in  	 IN	O
immunocompromised  	immunocompromised  	 JJ	B-NP
patients 	patients 	 NNS	I-NP
.  	.  	 .	O
Recently 	Recently 	 RB	O
,  	,  	 ,	O
this  	this  	 DT	O
viral  	viral  	 JJ	B-NP
infection  	infection  	 NN	I-NP
has  	has  	 VBZ	O
also  	also  	 RB	O
been  	been  	 VBN	O
reported  	reported  	 VBN	O
in  	in  	 IN	O
nonimmunocompromised  	nonimmunocompromised  	 VBG	O
critically  	critically  	 RB	O
ill  	ill  	 JJ	O
patients 	patients 	 NNS	O
.  	.  	 .	O
We  	We  	 PRP	O
hypothesize  	hypothesize  	 VBD	O
that  	that  	 DT	O
active  	active  	 JJ	O
cytomegalovirus  	cytomegalovirus  	 JJ	B-NP
infection  	infection  	 NN	I-NP
may  	may  	 MD	O
confound  	confound  	 VB	O
survival  	survival  	 NN	B-NP
outcomes  	outcomes  	 NNS	I-NP
in  	in  	 IN	O
severe  	severe  	 JJ	O
sepsis  	sepsis  	 NN	O
trials 	trials 	 NNS	O
.  	.  	 .	O
Scenarios  	Scenarios  	 NNS	O
based  	based  	 VBN	O
on  	on  	 IN	O
three  	three  	 CD	O
published  	published  	 VBN	B-NP
studies  	studies  	 NNS	I-NP
on  	on  	 IN	O
activated  	activated  	 JJ	O
protein  	protein  	 NN	B-NP
C  	C  	 NNP	I-NP
were  	were  	 VBD	O
used  	used  	 VBN	O
as  	as  	 IN	O
real  	real  	 JJ	O
examples  	examples  	 NNS	O
for  	for  	 IN	O
statistical  	statistical  	 JJ	B-NP
simulations  	simulations  	 NNS	I-NP
looking  	looking  	 VBG	O
for  	for  	 IN	O
how  	how  	 WRB	O
much  	much  	 JJ	O
bias  	bias  	 NN	O
in  	in  	 IN	O
favor  	favor  	 NN	O
of  	of  	 IN	O
or  	or  	 CC	O
against  	against  	 IN	O
activated  	activated  	 JJ	O
protein  	protein  	 NN	B-NP
C  	C  	 NNP	I-NP
would  	would  	 MD	O
be  	be  	 VB	O
observed  	observed  	 VBN	O
in  	in  	 IN	O
single-arm  	single-arm  	 JJ	B-NP
studies  	studies  	 NNS	I-NP
( 	( 	 -LRB-	O
scenario  	scenario  	 NN	O
1 	1 	 CD	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
phase  	phase  	 NN	O
II  	II  	 NNP	O
trials  	trials  	 NNS	O
( 	( 	 -LRB-	O
scenario  	scenario  	 FW	O
2A 	2A 	 FW	O
/ 	/ 	 FW	O
2B 	2B 	 FW	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
and  	and  	 CC	O
phase  	phase  	 NN	O
III  	III  	 NNP	O
trials  	trials  	 NNS	O
( 	( 	 -LRB-	O
scenario  	scenario  	 FW	O
3A 	3A 	 FW	O
/ 	/ 	 FW	O
3B 	3B 	 FW	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Scenario  	Scenario  	 NNP	O
1  	1  	 CD	O
simulations  	simulations  	 NNS	O
evaluated  	evaluated  	 VBD	O
a  	a  	 DT	O
single-arm  	single-arm  	 JJ	B-NP
study  	study  	 NN	I-NP
and  	and  	 CC	O
demonstrated  	demonstrated  	 VBN	O
that  	that  	 IN	O
confounding  	confounding  	 JJ	O
biases  	biases  	 NNS	O
could  	could  	 MD	O
cause  	cause  	 VB	O
an  	an  	 DT	O
absolute  	absolute  	 JJ	O
decrease  	decrease  	 NN	O
of  	of  	 IN	O
5.7 	5.7 	 CD	O
%  	%  	 NN	O
to  	to  	 TO	O
an  	an  	 DT	O
increase  	increase  	 NN	O
of  	of  	 IN	O
6.1 	6.1 	 CD	O
%  	%  	 NN	O
on  	on  	 IN	O
mortality  	mortality  	 NN	B-NP
rates  	rates  	 NNS	I-NP
of  	of  	 IN	O
similar  	similar  	 JJ	O
studies 	studies 	 NNS	O
.  	.  	 .	O
Scenarios  	Scenarios  	 NNP	O
2A  	2A  	 NNP	O
and  	and  	 CC	O
3A  	3A  	 CD	O
evaluated  	evaluated  	 JJ	O
phase  	phase  	 NN	O
II  	II  	 NNP	O
and  	and  	 CC	O
III  	III  	 NNP	O
trials  	trials  	 NNS	O
assuming  	assuming  	 VBG	O
that  	that  	 IN	O
activated  	activated  	 JJ	O
protein  	protein  	 NN	B-NP
C  	C  	 NNP	I-NP
is  	is  	 VBZ	O
truly  	truly  	 RB	O
effective 	effective 	 JJ	O
;  	;  	 :	O
they  	they  	 PRP	O
showed  	showed  	 VBD	O
that  	that  	 IN	O
trials  	trials  	 NNS	O
with  	with  	 IN	O
an  	an  	 DT	O
imbalance  	imbalance  	 NN	O
on  	on  	 IN	O
the  	the  	 DT	O
proportion  	proportion  	 NN	O
of  	of  	 IN	O
active  	active  	 JJ	O
cytomegalovirus  	cytomegalovirus  	 JJ	B-NP
infection  	infection  	 NN	I-NP
between  	between  	 IN	O
study  	study  	 NN	B-NP
arms  	arms  	 NNS	I-NP
could  	could  	 MD	O
lead  	lead  	 VB	O
to  	to  	 TO	O
false-negative  	false-negative  	 JJ	B-NP
rates  	rates  	 NNS	I-NP
( 	( 	 -LRB-	O
β  	β  	 JJ	O
errors 	errors 	 NNS	O
)  	)  	 -RRB-	O
in  	in  	 IN	O
up  	up  	 RB	O
to  	to  	 TO	O
25 	25 	 CD	O
%  	%  	 NN	O
of  	of  	 IN	O
phase  	phase  	 NN	O
II  	II  	 NNP	O
trials  	trials  	 NNS	O
and  	and  	 CC	O
up  	up  	 RB	O
to  	to  	 TO	O
42 	42 	 CD	O
%  	%  	 NN	O
of  	of  	 IN	O
phase  	phase  	 NN	O
III  	III  	 NNP	O
trials 	trials 	 NNS	O
.  	.  	 .	O
Scenarios  	Scenarios  	 NNP	O
2B  	2B  	 NNP	O
and  	and  	 CC	O
3B  	3B  	 NNP	O
assumed  	assumed  	 VBD	O
that  	that  	 DT	O
activated  	activated  	 JJ	O
protein  	protein  	 NN	B-NP
C  	C  	 NNP	I-NP
was  	was  	 VBD	O
truly  	truly  	 RB	O
ineffective 	ineffective 	 JJ	O
;  	;  	 :	O
they  	they  	 PRP	O
showed  	showed  	 VBD	O
that  	that  	 DT	O
imbalanced  	imbalanced  	 JJ	B-NP
cytomegalovirus  	cytomegalovirus  	 JJ	I-NP
infection  	infection  	 NN	I-NP
between  	between  	 IN	O
arms  	arms  	 NNS	O
would  	would  	 MD	O
cause  	cause  	 VB	O
false-positive  	false-positive  	 JJ	B-NP
rates  	rates  	 NNS	I-NP
( 	( 	 -LRB-	O
α  	α  	 JJ	O
errors 	errors 	 NNS	O
)  	)  	 -RRB-	O
in  	in  	 IN	O
up  	up  	 RB	O
to  	to  	 TO	O
5 	5 	 CD	O
%  	%  	 NN	O
of  	of  	 IN	O
phase  	phase  	 NN	O
II  	II  	 NNP	O
and  	and  	 CC	O
up  	up  	 RB	O
to  	to  	 TO	O
7 	7 	 CD	O
%  	%  	 NN	O
of  	of  	 IN	O
all  	all  	 DT	O
phase  	phase  	 NN	O
III  	III  	 NNP	O
trials 	trials 	 NNS	O
.  	.  	 .	O
The  	The  	 DT	O
inclusion  	inclusion  	 NN	O
of  	of  	 IN	O
an  	an  	 DT	O
imbalanced  	imbalanced  	 JJ	B-NP
proportion  	proportion  	 NN	I-NP
of  	of  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
active  	active  	 JJ	O
cytomegalovirus  	cytomegalovirus  	 JJ	B-NP
infection  	infection  	 NN	I-NP
may  	may  	 MD	O
severely  	severely  	 RB	O
compromise  	compromise  	 VB	O
the  	the  	 DT	O
reliability  	reliability  	 NN	O
of  	of  	 IN	O
outcome  	outcome  	 NN	B-NP
results  	results  	 NNS	I-NP
of  	of  	 IN	O
severe  	severe  	 JJ	O
sepsis  	sepsis  	 NN	O
trials  	trials  	 NNS	O
independent  	independent  	 JJ	O
of  	of  	 IN	O
their  	their  	 PRP$	O
design 	design 	 NN	O
.  	.  	 .	O
Even  	Even  	 RB	O
randomized  	randomized  	 JJ	B-NP
trials  	trials  	 NNS	I-NP
could  	could  	 MD	O
have  	have  	 VB	O
a  	a  	 DT	O
much  	much  	 RB	O
higher  	higher  	 JJR	O
probability  	probability  	 NN	B-NP
of  	of  	 IN	I-NP
false-negative  	false-negative  	 JJ	I-NP
rates  	rates  	 NNS	I-NP
for  	for  	 IN	O
a  	a  	 DT	O
new  	new  	 JJ	O
therapy  	therapy  	 NN	O
than  	than  	 IN	O
designed 	designed 	 VBN	O
.  	.  	 .	O
Future  	Future  	 JJ	O
severe  	severe  	 JJ	O
sepsis  	sepsis  	 NN	O
trials  	trials  	 NNS	O
should  	should  	 MD	O
consider  	consider  	 VB	O
including  	including  	 VBG	O
active  	active  	 JJ	O
cytomegalovirus  	cytomegalovirus  	 JJ	B-NP
infection  	infection  	 NN	I-NP
as  	as  	 IN	O
a  	a  	 DT	O
prospective  	prospective  	 JJ	B-NP
covariate 	covariate 	 NN	I-NP
.  	.  	 .	O
